Abnormality of the rib cage
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Acquired Kyphoscoliosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Autosomal Dominant Myotubular Myopathy
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Autosomal Recessive Centronuclear Myopathy
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Axial muscle weakness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Blepharoptosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Breast Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In this study we evaluated possible associations between breast cancer risk and survival and single nucleotide polymorphisms (SNPs) in the selenoprotein genes GPX1, GPX2, GPX3, GPX4, SELS, SEP15, SEPN1, SEPP1, SEPW1, TXNRD1, and TXNRD2 among Hispanic/Native American (2111 cases, 2597 controls) and non-Hispanic white (NHW) (1481 cases, 1586 controls) women in the Breast Cancer Health Disparities Study.
|
24278290 |
2013 |
Broad thumbs
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Bulbar palsy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Byzanthine arch palate
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Byzanthine arch palate
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Calf muscle hypertrophy
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cap Myopathy
|
0.010 |
Biomarker
|
disease |
BEFREE |
In the past year novel congenital myopathies have been suggested, genes have been discovered for some of the congenital myopathies for the first time (beta-tropomyosin in cap disease and perhaps skeletal muscle alpha-actin in Zebra body myopathy), further genes have been identified for congenital myopathies where other genes had already been found (cofilin in nemaline myopathy, selenoprotein N in congenital fibre type disproportion) and recessive myosin storage myopathy was associated with homozygous mutation of slow-skeletal/beta-cardiac myosin which was already known to be mutated in dominant myosin storage myopathy.
|
17885449 |
2007 |
Cardiac Arrhythmia
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Subjects with MDRS 5 had a risk of arrhythmia 12 times higher than patients with MDRS 1-2 (p<0.001).
|
19237383 |
2009 |
Cardiac conduction abnormality
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cardiomyopathy, Dilated
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Central Core Myopathy (disorder)
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Central Core Disease (CCD) and Multi-minicore Disease (MmD) (the "core myopathies") have been mainly associated with mutations in the skeletal muscle ryanodine receptor (RYR1) and the selenoprotein N (SEPN1) gene.
|
22784669 |
2012 |
Central Core Myopathy (disorder)
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Marked clinical variability corresponds to genetic heterogeneity: the most instantly recognizable classic phenotype characterized by spinal rigidity, early scoliosis and respiratory impairment is due to recessive mutations in the selenoprotein N (SEPN1) gene, whereas recessive mutations in the skeletal muscle ryanodine receptor (RYR1) gene have been associated with a wider range of clinical features comprising external ophthalmoplegia, distal weakness and wasting or predominant hip girdle involvement resembling central core disease (CCD).
|
17631035 |
2007 |
Central Core Myopathy (disorder)
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Patients with muscle symptoms in adulthood, who had features compatible with CCD/MmD, underwent clinical, histological, and genetic (RYR1 and SEPN1 genes) evaluations.
|
21674524 |
2011 |
Centrally nucleated skeletal muscle fibers
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Centronuclear myopathy
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Class III malocclusion
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Clumsiness - motor delay
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital clubfoot
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital Dysplasia Of The Hip
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|